Skip to main content

Meet our residents

PGY1

Aaron Lawson, PharmD

Dr. Aaron Lawson received his Doctor of Pharmacy from the University of Missouri - Kansas City School of Pharmacy in May 2020. His current practice interests include critical care, emergency medicine, and infectious disease. Dr. Lawson’s research project involves evaluating the process of tapering midodrine when used as an adjuvant to IV vasopressors. Upon completion of his PGY-1, he plans to pursue a PGY-2 or a clinical position in a hospital setting. Dr. Lawson also hopes to achieve board certification in pharmacotherapy.

Katie Luetkenhaus, PharmD

Dr. Katie Luetkenhaus received her Doctor of Pharmacy degree from the University of Missouri-Kansas City School of Pharmacy in May 2020. Dr. Luetkenhaus’ research project involves evaluating the dosing of intravenous ketorolac for acute pain in obstetric patients undergoing cesarean delivery. Upon completion of her PGY-1, Dr. Luetkenhaus plans to obtain board certification in pharmacotherapy and pursue a PGY-2 or a clinical position in an academic medical center.

Austin Miller, PharmD

Dr. Austin Miller received his Doctor of Pharmacy degree from the University of Iowa in May 2020. His current practice interest include critical care, emergency medicine, and infectious disease. Dr. Miller’s research project involves time to therapeutic range in obese vs. non-obese patients on heparin drips. Upon completion of his PGY-1, he plans to pursue a PGY-2 in critical care or a clinical position at a hospital in the Kansas City area.

Gadison Quick, PharmD

Dr. Gadison Quick received his Doctor of Pharmacy degree from the University of Missouri-Kansas City School of Pharmacy. Dr Quick’s research project involves evaluating the efficacy of vancomycin dosed per hospital protocol in the intravenous drug abuser population. Upon completion of his PGY-1, Dr. Quick plans to pursue a PGY-2 in either Internal Medicine or Emergency Medicine as well as obtain board certification in pharmacotherapy.

PGY2

Sara Lauterwasser, PharmD

Dr. Sara Lauterwasser received her Doctor of Pharmacy degree from Drake University in May 2019. She completed her PGY-1 residency at Truman Medical Center. Dr. Lauterwasser's research project involves evaluating the safety of heparin and enoxaparin in patients with a traumatic brain injury. Upon completion of her PGY-2, Dr. Lauterwasser plans to obtain board certification in critical care pharmacotherapy and hopes to stay in the Kansas City area to work as a critical care or emergency medicine clinical pharmacist in a hospital setting.